Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | OXTR | P30559 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL889703 | 0.88 | AVPR1A (0.40) | HPGDSMN1; SMN2AVPR1AKDM4EHSD17B10 | |
| SCHEMBL8281206 | 0.83 | NPC1 (0.38) | HPGDSMN1; SMN2KDM4EHSD17B10GLA | |
| SCHEMBL889699 | 0.81 | SMN1; SMN2 (0.44) | HPGDSMN1; SMN2AVPR1AKDM4EHSD17B10 | |
| SCHEMBL10127371 | 0.81 | POLB (0.39) | MCL1MAPT | |
| SCHEMBL889684 | 0.80 | SMN1; SMN2 (0.40) | HPGDSMN1; SMN2AVPR1AKDM4EHSD17B10 | |
| SCHEMBL10127925 | 0.80 | ATM (0.30) | SMN1; SMN2MAPK1MAPT | |
| SCHEMBL889583 | 0.79 | AVPR1A (0.44) | HPGDSMN1; SMN2AVPR1AKDM4EHSD17B10 | |
| SCHEMBL889639 | 0.79 | SMN1; SMN2 (0.43) | HPGDSMN1; SMN2AVPR1AKDM4EHSD17B10 | |
| SCHEMBL889589 | 0.79 | AVPR1A (0.46) | HPGDSMN1; SMN2AVPR1AKDM4EHSD17B10 | |
| SCHEMBL889602 | 0.79 | AVPR1A (0.46) | HPGDSMN1; SMN2AVPR1AKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9806268-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-9806268-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-20160285005-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20160285005-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
| US-9359335-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-06-07 | — | — | US | disclosed |
| US-9359335-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-06-07 | — | — | US | disclosed |
| US-20150197508-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-07-16 | — | — | US | disclosed |
| US-20150197508-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-07-16 | — | — | US | disclosed |
| US-8993125-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-31 | — | — | US | disclosed |
| US-8993125-B2 | Triazole derivative, and light-emitting element, light-emitting device, electronic device and lighting device using the triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20110285276-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150197508-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | DRD3, DRD1, GRK1 | HPGD 2094/4885SMN1; SMN2 4709/4885AVPR1A 839/4885 |
| US-20110285276-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | DRD3, DRD1, CYP1A1 | HPGD 1989/4885SMN1; SMN2 4747/4885AVPR1A 844/4885 |
| US-20160285005-A1 | Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device Using the Triazole Derivative | DRD3, DRD1, GRK1 | HPGD 2094/4885SMN1; SMN2 4709/4885AVPR1A 839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.